 |
|
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
Chenyang Li, Chujun Cai, Chendong Wang, Xiaoping Chen, Bixiang Zhang, Zhao Huang
Clin Mol Hepatol. 2025;31(2):350-381. Published online 2024 Dec 11 DOI: https://doi.org/10.3350/cmh.2024.0857
|
|
Citations to this article as recorded by
 Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
Sniedze Laivacuma, Olga Oblate, Aleksejs Derovs
Microorganisms.2025; 13(5): 1053. CrossRef
|